Russia’s largest drug company Pharmstandard has agreed a $590 million deal to buy the Singapore-based supplier of active pharmaceutical ingredients …
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time

